Scent test using Caenorhabditis elegans to screen for early-stage pancreatic cancer
- PMID: 34434497
- PMCID: PMC8378769
- DOI: 10.18632/oncotarget.28035
Scent test using Caenorhabditis elegans to screen for early-stage pancreatic cancer
Abstract
Although early detection and diagnosis are indispensable for improving the prognosis of patients with pancreatic cancer, both have yet to be achieved. Except for pancreatic cancer, other cancers have already been screened through scent tests using animals or microorganisms, including Caenorhabditis elegans. While such a method may greatly improve the prognosis of pancreatic cancer, no studies have investigated the same, mainly given the difficulty of collecting suitable samples from patients with early-stage pancreatic cancer. In this study, we organized a nationwide study group comprising high-volume centers throughout Japan to collect patients with very-early-stage pancreatic cancer (stage 0 or IA). We initially performed an open-label study involving 83 cases (stage 0-IV), with subsequent results showing significant differences after surgical removal in stage 0-IA (×10 dilution: p < 0.001; ×100 dilution: p < 0.001). Thereafter, a blinded study on 28 cases (11 patients with stage 0 or IA disease and 17 healthy volunteers) was conducted by comparing very-early-stage pancreatic cancer patients with healthy volunteers to determine whether C. elegans could detect the scent of cancer for the diagnosis of early-stage pancreatic cancer. Preoperative urine samples had a significantly higher chemotaxis index compared to postoperative samples in patients with pancreatic cancer [×10 dilution: p < 0.001, area under the receiver operating characteristic curve (AUC) = 0.845; ×100 dilution: p < 0.001, AUC = 0.820] and healthy volunteers (×10 dilution: p = 0.034; ×100 dilution: p = 0.088). Moreover, using the changes in preoperative and postoperative chemotaxis index, this method had a higher sensitivity for detecting early pancreatic cancer compared to existing diagnostic markers. The clinical application C. elegans for the early diagnosis of cancer can certainly be expected in the near future.
Keywords: Caenorhabditis elegans; biomarker; diagnosis; early-stage pancreatic cancer; scent test.
Copyright: © 2021 Asai et al.
Conflict of interest statement
CONFLICTS OF INTEREST Institutional endowments were partially received from Hirotsu Bio Science, Inc. (Tokyo, Japan); Kinshu-kai Medical Corporation (Osaka, Japan); IDEA Consultants, Inc. (Tokyo, Japan); Kyowakai Medical Corporation (Hyogo, Japan); Unitech Co., Ltd. (Chiba, Japan); Chugai Co., Ltd. (Tokyo, Japan); Yakult Honsha Co., Ltd. (Tokyo, Japan); and Ono Pharmaceutical Co., Ltd. (Osaka, Japan). N.K. and T.H. are employees of Hirotsu Bio Science, Inc.
Figures
Similar articles
-
A highly accurate inclusive cancer screening test using Caenorhabditis elegans scent detection.PLoS One. 2015 Mar 11;10(3):e0118699. doi: 10.1371/journal.pone.0118699. eCollection 2015. PLoS One. 2015. PMID: 25760772 Free PMC article.
-
Accuracy evaluation of the C. elegans cancer test (N-NOSE) using a new combined method.Cancer Treat Res Commun. 2021;27:100370. doi: 10.1016/j.ctarc.2021.100370. Epub 2021 Apr 9. Cancer Treat Res Commun. 2021. PMID: 33901923
-
[Development of an Early Cancer Detection Method Using the Olfaction of the Nematode Caenorhabditis elegans].Yakugaku Zasshi. 2019;139(5):759-765. doi: 10.1248/yakushi.18-00185-4. Yakugaku Zasshi. 2019. PMID: 31061346 Review. Japanese.
-
Behavioural Response Alteration in Caenorhabditis elegans to Urine After Surgical Removal of Cancer: Nematode-NOSE (N-NOSE) for Postoperative Evaluation.Biomark Cancer. 2019 Dec 24;11:1179299X19896551. doi: 10.1177/1179299X19896551. eCollection 2019. Biomark Cancer. 2019. PMID: 31903024 Free PMC article.
-
Screening for Skin Cancer in Adults: An Updated Systematic Evidence Review for the U.S. Preventive Services Task Force [Internet].Rockville (MD): Agency for Healthcare Research and Quality (US); 2016 Jul. Report No.: 14-05210-EF-1. Rockville (MD): Agency for Healthcare Research and Quality (US); 2016 Jul. Report No.: 14-05210-EF-1. PMID: 27583318 Free Books & Documents. Review.
Cited by
-
Application of Proteomics in Pancreatic Ductal Adenocarcinoma Biomarker Investigations: A Review.Int J Mol Sci. 2022 Feb 14;23(4):2093. doi: 10.3390/ijms23042093. Int J Mol Sci. 2022. PMID: 35216204 Free PMC article. Review.
-
Pancreatic Cancer Research beyond DNA Mutations.Biomolecules. 2022 Oct 17;12(10):1503. doi: 10.3390/biom12101503. Biomolecules. 2022. PMID: 36291712 Free PMC article. Review.
-
Cell-morphodynamic phenotype classification with application to cancer metastasis using cell magnetorotation and machine-learning.PLoS One. 2021 Nov 17;16(11):e0259462. doi: 10.1371/journal.pone.0259462. eCollection 2021. PLoS One. 2021. PMID: 34788313 Free PMC article.
-
Nematode-Applied Technology for Human Tumor Microenvironment Research and Development.Curr Issues Mol Biol. 2022 Feb 21;44(2):988-997. doi: 10.3390/cimb44020065. Curr Issues Mol Biol. 2022. PMID: 35723350 Free PMC article. Review.
-
C. elegans as a Powerful Tool for Cancer Screening.Biomedicines. 2022 Sep 23;10(10):2371. doi: 10.3390/biomedicines10102371. Biomedicines. 2022. PMID: 36289633 Free PMC article. Review.
References
-
- Fukuyama S, Mikami Y, Egawa S, Takeda K, Matsuno S. [Clinical classification and pathological physiology of acute pancreatitis]. [Article in Japanese]. Nihon Rinsho. 2004; 62:1973–76. - PubMed
-
- Yachida S, Jones S, Bozic I, Antal T, Leary R, Fu B, Kamiyama M, Hruban RH, Eshleman JR, Nowak MA, Velculescu VE, Kinzler KW, Vogelstein B, Iacobuzio-Donahue CA. Distant metastasis occurs late during the genetic evolution of pancreatic cancer. Nature. 2010; 467:1114–17. 10.1038/nature09515. - DOI - PMC - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources